arrow
G

Giovanni Butturini

Pederzoli Hospital
H指数:49
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: updated analysis of survival and circulating and genetic biomarkers from the phase II nITRO trial

可切除胰腺导管腺癌患者的围手术期NALIRIFOX方案:来自II期nITRO试验的生存率及循环和遗传生物标志物的更新分析

2026-05-050
OAAI
Integrating Genomics, Radiomics, and Pathomics in Oncology: A Scoping Review and a Framework for AI-Enabled Surgomics
2026-01-210
OAAI
Minimally invasive versus open left pancreatectomy for resectable pancreatic cancer: long-term results of the randomized DIPLOMA trial

微创与开放左胰腺切除术治疗可切除胰腺癌:DIPLOMA 随机试验的长期结果

2025-10-310
PRE
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial

基因组匹配疗法在晚期实体瘤中的应用:随机II期ROME试验

2025-09-290
OAAI
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial

癌症患者开放胰十二指肠切除术在加速康复计划中补充肠外营养:一项实用型、多中心、随机对照试验

2025-08-210
PREAI
Thirty-day prevalence and clinical impact of fluid collections at the resection margin after distal pancreatectomy: Follow-up of a multicentric randomized controlled trial
SURGERY
IF2.7
2024-07-011
PRE
Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus
2024-04-301
PRE
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer
2024-02-2611
OAAI
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
2024-01-043
OAAI
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial

可切除胰腺导管腺癌患者的围手术期NALIRIFOX: 开放标签,多中心,II期nITRO试验

2024-01-016
OA
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer
2023-11-106
PRE
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study
2022-12-209
OAAI